Sara, Roderick R.

HRN: 28-69-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2026
CLINDAMYCIN 300MG (CAP)
03/28/2026
04/02/2026
PO
300mg
Q8
Cellulitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: